Asthma has increased in prevalence over the last few decades. Several factors have been suggested to play a role in the increase of asthma prevalence…
Read More
What is Banti’s Syndrome?
Banti’s syndrome, a disorder of the spleen is characterized by the spleen prematurely destroying red blood cells. This syndrome is defined by abnormal spleen enlargement…
Read More
CDC initiative to combat antimicrobial resistance, infectious diseases
The Centers for Disease Control and Prevention (CDC) has awarded $22 million to nearly 30 organizations in 50 countries for efforts to combat antimicrobial resistance…
Read More
What are the Health Effects of Energy Drinks?
Concerns about the negative impact of energy drinks (ED’s) have arisen in recent years both in the scientific community and among the public. The risks…
Read More
$35 million to support study of sleep disorder linked to neurodegeneration
People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their…
Read More
Radiation therapy reprograms heart muscle cells to younger state
New research from Washington University School of Medicine in St. Louis suggests that radiation therapy can reprogram heart muscle cells to what appears to be…
Read More
2+2=? Senate Uses Murky Math as It Shelves Drug Pricing Rule to Fund Infrastructure
The Senate’s release of its bipartisan infrastructure plan signals that lawmakers are poised to throw former President Donald Trump’s belated bid to lower Medicare drug…
Read More
oteseconazole
oteseconazole Mycovia Pharmaceuticals Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis DURHAM, N.C.–(BUSINESS…
Read More
The Types of Hepatitis
Hepatitis is a general term to describe inflammation of the liver tissue. It can arise from several causes, although the commonest cause is a viral…
Read More
ruxolitinib
ruxolitinib Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis WILMINGTON, Del.–(BUSINESS WIRE)…
Read More